This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

J. Krasner, PhD; S. J. Yaffe, MD

Am J Dis Child. 1968;115(2):267-272.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

THE HAZARDS of drugs prescribed to newborn infants on the basis of information obtained in adults has emphasized the need for pharmacologic studies during this critical stage of development. Since alterations in metabolism have usually been responsible for the increased (drug) toxicity noted in the neonatal period, we have undertaken a systematic assay of these processes during postnatal development. Efforts have been concentrated on conjugation mechanisms in which a chemical moiety is coupled to the drug substrate, resulting in an increased water solubility of the conjugate and enhanced excretion. Glutathione (GSH) coupling to sulfobromophthalein is an example of this type of reaction.

Many studies have demonstrated that sulfobromophthalein (Bromsulphalein, BSP) is inadequately removed from the blood of full-term^1,2 and premature infants^3,4 during the neonatal period. Bromsulphalein concentrations decrease to adult values in the human infant at 3 to 4 weeks of age and appear to be related to . . . [Full Text PDF of this Article]

Author Affiliations
Buffalo

From the Department of Pediatrics, School of Medicine, State University of New York, Buffalo.

Footnotes
Received for publication Oct 23, 1967.

Submitted by the authors for the Mitchell I. Rubin Festschrift issue of the JOURNAL.

Reprint requests to 219 Bryant St, Buffalo 14222 (Dr. Yaffe).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?